Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Praxair Distribution, Inc. v. Mallinckrodt Hospital Products
Case Number:
16-2616
Court:
Nature of Suit:
Sectors & Industries:
-
May 25, 2018
Printed Matter Doctrine Case Could Offer New Patent Attack
A recent Federal Circuit decision applying the rarely-invoked printed matter doctrine to invalidate a respiratory drug patent could give litigants another way to challenge patents and get in patent-eligibility arguments that otherwise can't be made in inter partes reviews, attorneys say.
-
May 16, 2018
Fed. Circ. Nixes More Of Inomax Patent After PTAB Review
The Federal Circuit on Wednesday upheld the Patent Trial and Appeal Board's decision to invalidate the bulk of a Mallinckrodt patent on respiratory drug Inomax, then canceled an additional claim that judges said the board wrongly interpreted.